The Value of Functional Outcomes and Elevating Patient Voices in MS Assessments
August 1st 2025Panelists discuss how patient-reported outcomes are crucial for capturing MS symptoms like fatigue, depression, and cognitive decline that significantly impact working-age patients but require standardization for practical clinical integration.
Evaluating the Future of MS Therapies: Balancing Early Data With Delayed Outcomes
July 25th 2025Panelists discuss how the evaluation process must evolve to accommodate therapies that show benefits in slowing atrophy and motor decline over 1 to 2 years, emphasizing the need for early coverage rather than waiting for extensive long-term data.
Bridging the Gaps: BTK Inhibitors and the Future of MS Care
July 18th 2025Panelists discuss how BTK inhibitors represent a promising new oral therapy class that could address both inflammatory and neurodegenerative aspects of MS, particularly for progressive forms where treatment options are limited.